Development of Rapid Diagnostic Tests for Hantaviruses
汉坦病毒快速诊断测试的开发
基本信息
- 批准号:7169822
- 负责人:
- 金额:$ 96.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-15 至 2007-12-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibodiesBiological AssayBioterrorismBloodBreedingCardiopulmonaryCell surfaceClinicalCollaborationsComplementary RNADeer MouseDetectionDevelopmentDiagnosisDiagnosticDiagnostic testsDiagnostics ResearchDisease OutbreaksDoseEarly DiagnosisEpidemiologistEvaluationExhibitsFlow CytometryFundingGenetic TranscriptionGenomicsGenotypeHantavirusHantavirus InfectionsHaplotypesHospitalizationHourHumanImmune responseImmunoglobulin GImmunoglobulin MInbreedingIndividualInfectionMajor Histocompatibility ComplexMedicalMessenger RNAMethodologyMethodsModalityMusNew MexicoNucleic AcidsPathogenesisPathogenicityPatientsPeripheral Blood Mononuclear CellPlasmaPopulationPreventionProductionPublic HealthPurposeRNAReagentResearchResearch PersonnelResearch ProposalsRodentRoleSamplingScientistSensitivity and SpecificitySerumSeverity of illnessSiblingsSin Nombre virusSpeedSymptomsSyndromeTechnologyTestingTimeUniversitiesVariantViralViral AntigensViral Hemorrhagic FeversViral Load resultVirusVirus DiseasesWorkbasecell mediated immune responsechiron vaccinecytokinefollow-uphealth organizationimprovedmedical schoolsprogramstissue culturetoolviral RNA
项目摘要
DESCRIPTION (provided by applicant): The objectives of this research proposal are (1) to develop a rapid and easy-to-use nucleic acid diagnostic test to detect hantaviruses in blood, plasma, or serum of infected individuals and carrier rodents, (2) to develop a rapid diagnostic test to detect hantavirus antibodies in blood, plasma, or serum of infected individuals, (3) to develop a hantavirus nucleic acid discriminatory test, (4) to develop TaqMan-based quantitative assays to estimate hantavirus load in virus infected samples, (5) to develop a flow cytometry assay to detect Sin Nombre virus (SNV) antigen in peripheral blood mononuclear cells (PBMC) of patients with hantavirus cardiopulmonary syndrome (HCPS), (6) to develop inbred sublines of fully homozygous deer mice, and (7) to establish tools to dissect deer mouse cellular immune responses to hantavirus infection. The hantavirus nucleic acid and antibody diagnostic tests should be able to yield results in less than one hour, and will assist in the early detection and follow up of hantavirus infections. The availability of the hantavirus nucleic acid discriminatory assay will allow identification of specific viral isolates involved in hantavirus outbreaks and their possible origins. Methods to accurately quantitate hantavirus load in human patients or in animal models, along with the availability of a flow cytometry-based SNV assay, inbred homozygous deer mice, and methodologies to dissect the deer mouse cellular immune responses to hantavirus will facilitate better understanding, prevention, and treatment of hantavirus infections. This research involves collaborative efforts between Chiron Corporation and the School of Medicine, University of New Mexico. A previous collaboration between the two organizations was initiated in 1994 but discontinued in 1997 when Chiron Corporation withdrew funding for hantavirus diagnostic research, as there was no strategic fit at that time. The information generated from the studies proposed in this task will be crucial for the rapid identification of possible bioterrorism attacks involving hantavirus agents and will be vital to assist the medical and public health organizations to efficiently respond to hantavirus outbreaks and/or threats.
描述(由申请人提供):本研究计划的目标是 (1) 开发一种快速且易于使用的核酸诊断测试,以检测受感染个体和带菌啮齿动物的血液、血浆或血清中的汉坦病毒,(2 ) 开发快速诊断测试来检测感染个体的血液、血浆或血清中的汉坦病毒抗体,(3) 开发汉坦病毒核酸区分测试,(4) 开发基于 TaqMan 的定量测定法来估计汉坦病毒载量病毒感染的样本,(5) 开发流式细胞术检测汉坦病毒心肺综合征 (HCPS) 患者外周血单核细胞 (PBMC) 中的 Sin Nombre 病毒 (SNV) 抗原,(6) 开发完全纯合的近交亚系鹿小鼠,以及(7)建立工具来剖析鹿小鼠对汉坦病毒感染的细胞免疫反应。汉坦病毒核酸和抗体诊断检测应能在不到一小时内得出结果,将有助于汉坦病毒感染的早期发现和随访。汉坦病毒核酸鉴别测定的可用性将有助于鉴定参与汉坦病毒爆发的特定病毒分离株及其可能的起源。准确定量人类患者或动物模型中汉坦病毒载量的方法,以及基于流式细胞术的 SNV 检测、近交纯合鹿小鼠以及剖析鹿小鼠对汉坦病毒的细胞免疫反应的方法,将有助于更好地理解和预防,以及汉坦病毒感染的治疗。这项研究涉及 Chiron 公司和新墨西哥大学医学院的合作。两个组织之前的合作始于 1994 年,但由于当时没有战略契合,Chiron 公司撤回了对汉坦病毒诊断研究的资助,因此于 1997 年终止。本任务中提出的研究产生的信息对于快速识别涉及汉坦病毒制剂的可能的生物恐怖袭击至关重要,并且对于协助医疗和公共卫生组织有效应对汉坦病毒爆发和/或威胁也至关重要。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Recognition of decay accelerating factor and alpha(v)beta(3) by inactivated hantaviruses: Toward the development of high-throughput screening flow cytometry assays.
- DOI:10.1016/j.ab.2010.03.016
- 发表时间:2010-07-15
- 期刊:
- 影响因子:2.9
- 作者:Buranda T;Wu Y;Perez D;Jett SD;BonduHawkins V;Ye C;Edwards B;Hall P;Larson RS;Lopez GP;Sklar LA;Hjelle B
- 通讯作者:Hjelle B
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sergio Pichuantes其他文献
Sergio Pichuantes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sergio Pichuantes', 18)}}的其他基金
Development of Rapid Diagnostic Tests for Hantaviruses
汉坦病毒快速诊断测试的开发
- 批准号:
7009298 - 财政年份:2003
- 资助金额:
$ 96.47万 - 项目类别:
Development of Rapid Diagnostic Tests for Hantaviruses
汉坦病毒快速诊断测试的开发
- 批准号:
6602882 - 财政年份:2003
- 资助金额:
$ 96.47万 - 项目类别:
Development of Rapid Diagnostic Tests for Hantaviruses
汉坦病毒快速诊断测试的开发
- 批准号:
6847409 - 财政年份:2003
- 资助金额:
$ 96.47万 - 项目类别:
Development of Rapid Diagnostic Tests for Hantaviruses
汉坦病毒快速诊断测试的开发
- 批准号:
6776436 - 财政年份:2003
- 资助金额:
$ 96.47万 - 项目类别:
相似国自然基金
新细胞因子FAM19A4联合CTLA-4抗体在肿瘤治疗的功能和机制研究
- 批准号:32370967
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于吡啶盐的可裂解抗体-药物偶联方法研究
- 批准号:22307081
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于淬灭抗体的重金属镉快速定量免疫分析
- 批准号:22306074
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TFAM条件性敲除重塑树突状细胞免疫代谢增强PD-1抗体抗肿瘤作用的机制研究
- 批准号:82303723
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 96.47万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 96.47万 - 项目类别:
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
- 批准号:
10641225 - 财政年份:2023
- 资助金额:
$ 96.47万 - 项目类别:
Fluorescent probes for detection of misfolded protein oligomers in Alzheimer's Disease and related disorders
用于检测阿尔茨海默病和相关疾病中错误折叠蛋白寡聚体的荧光探针
- 批准号:
10604908 - 财政年份:2023
- 资助金额:
$ 96.47万 - 项目类别: